We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+497.97%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
1
ExxonMobil
XOM
$634B
$49M 5.17%
592,726
-10,711
-2% -$853K
AAPL icon
2
Apple
AAPL
$4.99T
$44.8M 4.72%
967,064
-8,316
-0.9% -$377K
JNJ icon
3
Johnson & Johnson
JNJ
$643B
$31.5M 3.32%
259,512
-4,785
-2% -$597K
TMO icon
4
Thermo Fisher Scientific
TMO
$214B
$23.3M 2.46%
112,571
+1,417
+1% +$301K
JPM icon
5
JPMorgan Chase
JPM
$950B
$20.5M 2.17%
197,144
+14,780
+8% +$1.62M
DD icon
6
DuPont de Nemours
DD
$19B
$19.7M 2.08%
118,160
+9,033
+8% +$1.51M
MSFT icon
7
Microsoft
MSFT
$2.92T
$18.9M 1.99%
191,181
+2,022
+1% +$196K
PYPL icon
8
PayPal
PYPL
$50.3B
$18.7M 1.98%
225,035
-125
-0.1% -$9.96K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.08T
$17.4M 1.83%
307,720
+14,440
+5% +$785K
MRK icon
10
Merck
MRK
$326B
$17M 1.79%
292,906
+1,382
+0.5% +$78K
NEE icon
11
NextEra Energy
NEE
$186B
$16.9M 1.78%
403,784
-9,680
-2% -$391K
BP icon
12
BP
BP
$107B
$16.4M 1.73%
381,444
-4,589
-1% -$193K
V icon
13
Visa
V
$697B
$15.8M 1.67%
119,669
+4,046
+3% +$521K
SPY icon
14
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$15.1M 1.6%
55,793
+265
+0.5% +$71.6K
BA icon
15
Boeing
BA
$175B
$15.1M 1.59%
44,960
-2,278
-5% -$784K
NSC icon
16
Norfolk Southern
NSC
$76.1B
$13.9M 1.47%
92,111
-4,065
-4% -$594K
INTC icon
17
Intel
INTC
$435B
$13.9M 1.46%
279,225
-3,196
-1% -$170K
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.07T
$13.8M 1.46%
247,680
+1,460
+0.6% +$78.9K
ZTS icon
19
Zoetis
ZTS
$32.5B
$13.2M 1.39%
154,487
+2,153
+1% +$182K
CVX icon
20
Chevron
CVX
$374B
$11.5M 1.21%
90,650
+4,395
+5% +$546K
MDY icon
21
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$11.3M 1.19%
31,832
-692
-2% -$243K
MCD icon
22
McDonald's
MCD
$194B
$11.1M 1.18%
71,148
– –
DIS icon
23
Walt Disney
DIS
$172B
$10.8M 1.14%
103,293
-2,545
-2% -$260K
ORCL icon
24
Oracle
ORCL
$346B
$10.8M 1.13%
244,077
-6,345
-3% -$292K
ABBV icon
25
AbbVie
ABBV
$465B
$10.6M 1.12%
114,450
-4,570
-4% -$446K
1
2 3 4 5

Similar funds

PMFA
Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.55B AUM 14.55% 1-Year Est. Return
IWA
Icon Wealth Advisors Houston, Texas $1.54B AUM 18.41% 1-Year Est. Return
ZBNA
Zions Bancorporation, National Association Salt Lake City, Utah $1.55B AUM 19% 1-Year Est. Return
BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.55B AUM 28.47% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.